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B cell responses to Salmonella proceed
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center pathways. Shlomchik and
colleagues show that such responses are
characterized by promiscuous, yet
specific B cell activation, followed by
extrafollicular somatic hypermutation,
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TheB cell response toSalmonella typhimurium (STm)
occurs massively at extrafollicular sites, without
notable germinal centers (GCs). Little is known in
terms of its specificity. To expand the knowledge
of antigen targets, we screened plasmablast (PB)-
derivedmonoclonal antibodies (mAbs) forSalmonella
specificity, using ELISA, flow cytometry, and antigen
microarray. Only a small fraction (0.5%–2%) of the
response appeared to be Salmonella-specific. Yet,
infection of mice with limited B cell receptor (BCR)
repertoires impaired the response, suggesting that
BCR specificity was important. We showed, using
laser microdissection, that somatic hypermutation
(SHM) occurredefficiently at extrafollicular sites lead-
ing to affinity maturation that in turn led to detectable
STm Ag-binding. These results suggest a revised
vision of how clonal selection and affinity maturation
operate in response to Salmonella. Clonal selection
initially is promiscuous, activating cells with virtually
undetectable affinity, yet SHM and selection occur
during the extrafollicular response yielding higher
affinity, detectable antibodies.
INTRODUCTION
The immune response to microorganisms is an interplay
between aspects of innate and adaptive immunity. Successful
pathogens often have multiple mechanisms to evade or subvert
the immune response. Furthermore, pathogens contain molecu-
lar patterns that stimulate a wide variety of innate immune
pattern-recognition receptors, whether expressed on innate
cells such as macrophages, dendritic cells (DCs), or on adaptive
cells such as B lymphocytes. These pathways and innate recep-
tor ligands in turn shape adaptive immunity.120 Immunity 43, 120–131, July 21, 2015 ª2015 Elsevier Inc.Currently, our knowledge of B cell responses is mostly
based on artificial systems that lack these natural innate
immune cues. Instead, they use non-replicating antigens
given in adjuvant. The ‘‘canonical’’ response described in
these models includes a rapid transient extrafollicular (EF)
plasmablast (PB) response followed by germinal center (GC)
appearance (Shlomchik and Weisel, 2012). While some path-
ogen responses follow this progression (e.g., the response to
influenza [Coro et al., 2006; Moyron-Quiroz et al., 2004; Ono-
dera et al., 2012; Rothaeusler and Baumgarth, 2010]), there
is increasing evidence that in many other infections this is
not the case. During Ehrlichia muris infection splenic GC for-
mation is suppressed (Racine et al., 2010). Similarly, Borrelia
burgdorferi interferes with the B cell response by affecting its
quality and kinetics, delaying GC appearance and instead
stimulating immunoglobulin M (IgM) antibody-forming cells
(AFCs) (Hastey et al., 2012).
Though the immune response to Salmonella enterica serovar
Typhimurium (STm), a facultative intracellular gram negative
bacterium, is relatively well studied (Dougan et al., 2011), infor-
mation on the B cell response is limited. This is a major omis-
sion, considering that STm is a clinically relevant microorganism
and that live attenuated strains have been proposed and are in
phase I clinical trials as vectors for vaccines (Kong et al., 2012).
Furthermore, STm and related serovars are a major cause of
infectious diarrhea in the developed world and they are also
responsible for serious disseminated infections in Africa and
Asia. It is highly homologous to Salmonella Typhi, and consid-
ered a murine model for the study of this pervasive human path-
ogen. The B cell response to STm can be protective in both
mice and humans, via antibodies or other mechanisms (Nanton
et al., 2012).
STm induces a massive extrafollicular AFC response in the
spleen, while GC formation is greatly delayed (Cunningham
et al., 2007). Both T-dependent (TD) and T-independent (TI) com-
ponents contribute to the response (Gil-Cruz et al., 2009). The
mechanisms that shape this type of B cell response remain to
be elucidated, whereas parameters of virulence and protection
have received greater attention. Deletion of the signaling adaptor
Figure 1. STm Infection Induces a Rapid,
Massive AFC Response without GCs
(A) Spleen weight (red line) and splenic bacterial
burden (black line) in infected mice over time.
(B–E) Immunofluorescence staining of cry-
osections from spleens of infected mice for GCs
(B, day 11; C, day 28), AFC patches (D, day 4,
arrows) and isotype-switched IgG2c AFCs
(E, day 11).
(F and G) Analysis of the abundance of AFCs by
ELISpot (F) or of plasmablasts and GC cells by
flow cytometry (G, gating as reported in Figure S1).
Data shown here are representative of at least six
independent experiments. In (A), (F), and (G), data
are represented asmean ± SD of groups of at least
five mice. See also Figure S1.MyD88 appeared to favor, rather than inhibit, STm virulence
(Arpaia et al., 2011; Barr et al., 2010; Neves et al., 2010).
A number of studies have addressed the targets of the B cell
response, yet overall these remain poorly defined. LPS, outer
membrane proteins (OMPs) and possibly flagellin are identified
as primary Ags of the switched Ab response (Bobat et al.,
2011; Caldero´n et al., 1986; Cunningham et al., 2007; Ortiz
et al., 1989; Singh et al., 1992). Recently, some of the authors
of the present work have screened immune sera on antigen
(Ag) microarrays, thus identifying antibody (Ab) signatures of
human and murine Salmonellosis (Lee et al., 2012). Serum
signatures can partly describe the status of the Ab response,
but they do not reveal its ontogeny; moreover, serum Ab
profiles might be discordant with memory or effector cell
specificities (Guan et al., 2009). Knowing antigenic targets is
certainly important for vaccine design, yet further research is
necessary to understand the underlying mechanisms of
response and protection; for instance, to explain why vaccines
to Salmonella have only moderate, transient efficacy (McGre-
gor et al., 2013).
Here we focused both on defining the specificities of the
B cell response and addressing why it follows an extrafollicularImmunity 43, 120–pathway rather than a GC one. Our initial
hypothesis was that the massive plas-
mablast response was polyclonal and
non-specific, owing to innate immune re-
ceptor stimulation of B cells. Initial evi-
dence indicated that the response was
apparently non-specific. However, a
series of experiments using a variety of
approaches ultimately revealed a pro-
cess in which very low affinity, yet
specific, B cells—found at unexpectedly
high precursor frequency—join the initial
proliferative plasmablast response, and
in the absence of developed GCs eventu-
ally acquired somatic mutations which in
turn led to sufficient affinity maturation
for the ultimate detection of conventional
‘‘specificity’’ for the immunizing bacteria.
These results reveal an unappreciated
pathway of response to a gram-negativebacterial pathogen and in addition lead to a revised view of the
nature of clonal selection, specificity, affinity, and humoral im-
mune response evolution.
RESULTS
STm Infection Induces Rapid AFCAccumulation, but Not
GC Formation, in the Spleen
Following intraperitoneal (i.p.) administration of an aroA attenu-
ated STm strain (Hoiseth and Stocker, 1981), rapid spreading
of bacteria to several organs was observed, including to the liver,
the gut, and especially the spleen, which rapidly increased in size
(Figure 1A). Consistently with previous reports (Cunningham
et al., 2007), there were few if any detectable GCs (Figures 1B
and 1C) but there was massive accumulation of AFCs at EF
sites (bright cell patches positive for intracellular Ig, Figure 1D).
Of note, extensive class switching to IgG was detected at early
stages of the response, with IgG2c as the dominant isotype (Fig-
ure 1E and [Cunningham et al., 2007]). We determined the
kinetics of AFC accumulation and GC formation (Figures 1F
and 1G) during the early to mid-phase (up to 30 days) of the im-
mune response. The IgM AFC response was present at 4 days131, July 21, 2015 ª2015 Elsevier Inc. 121
Figure 2. Screening of the Specificity of the
AFC Response
(A and B) ELISpot assays for Ag-specific IgG AFCs
(Ags: LPS, OmpA, STm lysate) shown as total
number of cells per spleen (A) or as percentage of
the IgG and IgM AFC compartment (B).
(C) Schematic panel illustrating the hybridoma
production and screening strategy and method-
ologies. In the example showed here, an IgG mAb
which was selected in the first screening is then
probed on the Ag microarray, where LppA and
LppB (proteins with high homology) were identi-
fied as the antigenic targets.
(D and E) Summary of the frequency of Ag-specific
IgG (D) or IgM (E) mAbs from hybridomas identified
after the screening. Data shown in (A) and (B) are
representative of at least six independent experi-
ments and are represented as mean ± SD of
groups of at least five mice. See also Figure S2.post-infection and peaked before 2 weeks, while the IgG
response appeared and peaked slightly later but was remarkably
larger in size, showing about a 50-fold expansion from baseline.
The flow cytometry analysis showed a slight increase in the
frequency of cells with a GC phenotype starting 3 weeks after
infection, in contrast to immunofluorescence analysis, which
we further addressed below.
Only a Minority of the AFCs Can Be Assigned to
Salmonella Specificity
The massive AFC response led us to investigate the specificity
of it. Given the limited knowledge and availability of STm Ags,122 Immunity 43, 120–131, July 21, 2015 ª2015 Elsevier Inc.we used amulti-pronged approach. First,
we performed ELISpot assays using
some of the few known Ags which are
thought to be major targets, such as
LPS and the outer membrane protein
OmpA (Lee et al., 2012). In order to
enumerate Ag-specific cells more
broadly, we also used a lysate of STm
as target. The percentage of AFCs spe-
cific for all of these Ags together was
less than 0.5%of IgG and 2%of IgM (Fig-
ures 2A and 2B); this low frequency sug-
gests that the vast majority of the STm
AFC response is non-specific. However,
ELISpot assays could lack sensitivity if
the Ag concentration or the Ab affinities
are low, although it must be said that
even very low affinity hapten Abs can be
detected by ELISpot, provided that the
Ab is IgM (Dal Porto et al., 2002).
Some of these issues can be overcome
by producing mAbs and investigating the
specificity at the single cell level. Using
the traditional hybridoma technique (Fig-
ure 2C) we produced mAbs at an early
(day 7) and late (day 21) time point, ob-
taining an extensive panel of both IgM
(1,110) and IgG (650) lines. We initiallyscreened all lines by ELISA (on the same Ags described above)
and 480 of them by both ELISA and a flow cytometry assay
that uses whole STm cells as a source of native Ag (Figure 2C).
This process identified several lines that were either LPS-spe-
cific, STm-specific (mAbs reactive either to the lysate in ELISA
or in the flow cytometry assay), or polyreactive (mAbs binding
to more than one Ag, including control proteins such as GST
and BSA in ELISA). A Salmonella Ag microarray has recently
become available (Lee et al., 2012) and represents a powerful
tool to dissect the specificity of the response. Because the multi-
plexing capability of the Ag microarray screening is currently
relatively low, we tested all STm-specific clones (n = 20, 8 IgG
Figure 3. Infection of Genetically Modified Mouse Strains
(A–D) Assessment of the TLR-dependent component of the response.
Wild-type B6,Myd88/B6, and TLR2-TLR4/B6micewere infected and the
AFC response was evaluated by Elispot for total IgG (solid lines in A) and IgM
(dotted lines in A), LPS (B), STm lysate (C), and OmpA (D). Because infection
with the standard dose used throughout our study resulted in high mortality
rate in Myd88-deficient mice (not shown), these were infected with a lower
amount of STm (2 3 104), which permitted 100% survival after 30 days.
(E–G) Mice with engineered Ab genes/BCR were infected and the splenic
AFC response was measured for: total IgG in wild-type C57BL/6, B1.8+/+
(C57BL/6), or B1.8+/+ Jk/mice (C57BL/6) (E); total IgG (F) or OmpA-specific
IgG (G) in wild-type Balb/c, Vk8R+/+ (BALB/c), or Jk/ (Balb/c) mice. In all
panels data are representative of at least two independent experiments and
are represented as mean ± SD of groups of at least four mice.and 12 IgM), and representative randomly selected ‘‘negative’’
lines (n = 55, 31 IgG and 24 IgM). For IgGmAbs, of the 8 assayed
that were positive in the first screening 2were further assigned to
an Ag specificity. Of the 31 additional IgG mAbs, only one iden-
tified a target on the microarray. For the IgM, of the 12 positive
mAbs, 3 identified a target on the array whereas 7 were shown
to be polyreactive. Of the 24 randomly selected IgM mAbs,
6 bound an Ag on the microarray and 5 more were polyreactive.
Representative profiles of polyreactivity, as well as of identified
targets, that included NhaA, LppA/B, YbhC for IgG, and YjcS,
HybG, FadD, DnaJ, OmpA, HemB, AphA for IgM, are shown in
Figure S2. In summary (Figures 2D and 2E), by combining ELISA,
flow cytometry, andmicroarray screening, we identified 21 STm-
specific and 10 LPS-specific along with 31 polyreactive (30 IgM
and 1 IgG) mAbs. It is striking that only 1 in 31 randomly selected
IgG mAbs found a microarray hit, and that in general our exten-
sive screening of 650 IgG mAbs led to the identification of only
11 STm-specific (1.7%) and 8 LPS-specific (1.2%) mAbs. This
is consistent with the ELISpot, ELISA, and flow cytometry data,
and strongly suggest that the great majority of IgG mAbs lack
either specificity or sufficient affinity to be assigned to STm
specificity.
TLR and IL-1R Signaling, and to Some Degree T Cells,
Are Dispensable for AFC Responses
The specificity screening raised the question of whether STm
induces a non-specific polyclonal plasmablast response; for
instance, signaling via Toll-like receptors (TLRs) could be
responsible for non-specific expansion of AFCs, such as in the
case of the TI Ag LPS known in some cases to generate large
amounts of isotype switched Abs (Koga et al., 1985). To test
this possibility, we infected mice deficient for TLR2 and TLR4,
as well as mice deficient for the adaptor protein MyD88 that
signals downstream of all but one TLR (Figure 3). In both cases,
a large switched and unswitched plasmablast response was still
generated (Figure 3A), to an amount comparable to or higher
than wild-type mice. Consistently, LPS-, lysate-, and OmpA-
specific AFCs were detected in all three strains (Figures 3B–
3D). Because interleukin-1 receptor (IL-1R)-family members
also signal via MyD88, these data also exclude this axis as a
likely source of non-specific B cell activation. This was confirmed
in mice deficient for IL-1R as well as ASC (data not shown),
excluding these canonical inflammasome-mediated mecha-
nisms. It has been suggested that T cell signals contribute to se-
lection; however, in the STm infection model, at least part of the
EF response is independent of T cells (Figure S3 and [Gil-Cruz
et al., 2009]). Together these data exclude key innate immune
pathways, while suggesting that a substantial though not com-
plete response can occur in the absence even of T cell signals.
A Diverse BCR Repertoire Is Required for Mounting the
AFC Response
We then investigated the B cell receptor (BCR) specificity
requirement for the response to take place. We reasoned that,
if specific sensing of Ags via the BCR were required for B cell
activation, then limiting the BCR repertoire should affect the
response; whereas, if the response were truly non-specific (i.e.,
independent of BCR specificity), then it should be unaffected
by restricting the BCR repertoire. This can be accomplished inImmunity 43, 120–131, July 21, 2015 ª2015 Elsevier Inc. 123
various mice with engineered Ab genes (Figures 3E–3G). First,
we infected mice homozygous for the B1-8 IgH site-directed
transgene, which have a single VH and variable VL genes. These
mice showed a dramatic reduction in the IgG AFC response
(Figure 3E). The response could be further curtailed to back-
ground amounts in B1-8+/+ Jk/ mice, where the VL repertoire
was restricted to the l locus. Similarly, infection of Vk8R+/+
mice and Jk/mice, both of which have variable VH but limited
VL repertoires, showed a marked reduction in the quantity (Fig-
ure 3F) and quality (Figure 3G) of the IgG AFC response. Thus,
a limited BCR repertoire resulted in a markedly diminished total
and Ag-specific IgG response. These results indicate that indeed
certain BCRs are selected by STm Ag, consistent with standard
clonal selection theory.
The B Cell Response to STm Comprises a Subset of the
Repertoire Undergoing Vigorous Somatic
Hypermutation
It was conceivable that the inability to detect Ag specificity in the
early response was due to low affinity of the great majority of
responding B cells. If this were true, specificity would mainly
be detected as a result of affinity maturation driven by somatic
hypermutation (SHM). This scenario, which requires time, was
suggested by the fact that LPS- or lysate-specific AFCs ap-
peared later in the response. Furthermore, if the response were
indeed specific at the outset, then the responding repertoire of
BCRs should be narrower than the overall repertoire.
To assess to what extent SHM takes place, as well as the
breadth and clonality of the responding repertoire of B cells,
we performed high throughput sequencing of heavy chain VDJ
mRNA. We employed a single-molecule barcoding strategy to
tag each starting mRNA with a unique molecular identifier
(UID), enabling computational assembly of unique mRNA ampli-
fication products into low-error consensus sequences (Shugay
et al., 2014; Vander Heiden et al., 2014; Vollmers et al., 2013).
This mitigates the impact of sequencing error, and improves
the accuracy of mutation identification (Figure S4). The reper-
toires of plasmablast populations, sorted at either an early
(day 7) or a late (day 21) time point, were compared to naive
B cells, further divided in follicular (FO) and marginal zone (MZ)
B cells.We analyzed approximately 14million raw reads, yielding
346,349 and 3,885 unique, high-confidence VDJ arrangements
from all naive and PB samples, respectively (Figure S4 and Table
S1). The response was diverse (Figure 4A), with a representation
of all VH families and very limited evidence for preferential usage
of VH or JH genes by plasmablasts (Figure S4). Nonetheless,
when examined at the level of individual sequence diversity,
the plasmablast response showed clear signs of expansion
and selection (Figure 4B and Figure S4). Clonal diversity was
characterized using the general diversity index (qD) proposed
by Hill (Hill, 1973), which encompasses a range of commonly
used diversity measures as a smooth curve over a single varying
parameter q (see Supplemental Information). According to this
approach, the overall diversity of the naive population was
similar between marginal zone and follicular B cell samples (Fig-
ure 4B). In contrast, the plasmablast populations at both day 7
and day 21 post infection had a lower qD index for all q indicating
that they were significantly more focused (i.e., exhibited reduced
diversity) compared to the naive repertoire. This reduction in di-124 Immunity 43, 120–131, July 21, 2015 ª2015 Elsevier Inc.versity was apparent in terms of both the total number of clones
(q/ 0) and clonal dominance (q/ N). This pattern was un-
changed when considering diversity for each isotype separately
(data not shown).
In order to assess whether the reduced diversity of the plas-
mablast response was evidence for antigen specificity, rather
than a result of stochastic expansion of non-specific clones,
we compared the repertoire diversity shift induced in vitro by
a non-antigen-specific stimulus, such as CpG, which elicits
proliferation of both follicular and MZ B cells. Figure 4C shows
that stimulated and divided B cells had very similar repertoire
diversity as untreated or non-divided cells, which was different
from what was observed for the STm plasmablast repertoire
(Figure 4B).
Finally, we analyzed the mutational content of the sorted pop-
ulations (Figures 4D–4F and Table 1). Three weeks after infec-
tion, the average number of mutations per sequence was 5.6
(3.4, 6.7, and 8.6 for IgM, IgG, and IgA, respectively), rising
from 3.7 (3.0, 3.8 and 8.8) at day 7 and a background amount
in naive cells of 0.9. Mutations in the naive sequences are a
consequence, at least in part, of sequencing and germline data-
base errors, as well as possibly mutations in the preimmune
repertoire and the inclusion of natural IgM memory B cells that
share surface markers with naive B cells (Tomayko et al.,
2010). Taking this into account, even when only sequences
with more than one mutation were included in the analysis, the
average frequency of mutated Ab genes at 21 days post-infec-
tion was 50% (24%, 47%, and 83% for IgM, IgG, and IgA,
respectively), compared to 31% (23%, 40%, and 73% for IgM,
IgG, and IgA, respectively) at day 7 and 7% in naive samples.
Hence, STm-elicited plasmablasts contain numerous mutations
and the mutational content increases over time, while the diver-
sity of the responding plasmablasts is significantly narrower than
either the FO or MZ preimmune repertoire. Both of these are
consistent with selection despite the apparent lack of specificity.
SHM Takes Place in Follicles and at Extrafollicular Sites
Given evidence for extensive SHM, it was compelling to investi-
gate where it takes place. The appearance of specific AFC
occurring prior to GC formation would be consistent with ex-
tra-GC SHM and Ag-driven affinity maturation. Although SHM
does not canonically happen at EF sites, it does occur in murine
spleen in the autoimmune setting (William et al., 2002), showing
that GCs are not strictly necessary for this process; however, a
physiological counterpart to extra-GC mutation has to date not
been revealed in a murine pathogen-specific response. The
rapid appearance of isotype-switched plasmablasts post-infec-
tion shows that activation-induced cytidine deaminase (AID) is
activated very early in the response among extrafollicular B cells,
making it plausible to think that SHM could also be occurring.
To resolve this, we first searched for GC-like structures that
might have been an alternative site for SHM. The apparent
contrast between the lack of GCs as assessed by immunofluo-
rescence and the flow cytometric detection of cells with a GC
phenotype (Figure 1), the frequencies of which admittedly did
not rise above baseline until day 22, could be reconciled by the
finding, starting 3 weeks after infection, of scattered small
PNA-positive cell aggregates in some sections. The cells in these
small clusters expressed the PNA target weakly, as they were
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Figure 4. Repertoire Characteristics of the Plasmablast Response to STm Infection
IgM sequences of naive follicular (FO) and marginal zone (MZ) B cells from uninfected mice were compared to IgM, IgG, and IgA sequences from plasmablasts
7 days (D7PB) and 21 days (D21PB) post-infection.
(A) V family usage (x axis) shown for different isotypes as the percentage (y axis) of processed sequences within each sample.
(B) Comparison of the Hill diversity index (qD, y axis) over varying diversity orders q (see Supplemental Information), between IgM sequences from naive samples
and IgM, IgG, and IgA sequences from samples of infected mice. The median diversity score over all resampling realizations is plotted as a line with the middle
95% percentile of the resampled distribution indicated by a shaded background. All samples were randomly downsampled to 800 sequences for each re-
sampling realization to correct for variations in sequencing depth.
(C) Comparison of Hill diversity indices between IgM sequences grown in cell culture under three conditions: untreated, cells that proliferated after CpG
treatement (CpG div), and cells that did not proliferate after CpG treatment (CpG non-div). All samples were uniformly downsampled to 800 sequences for
comparison to (C).
(D–F) Violin plots showing the distribution of mutations from the germline (y axis) for each sample (x axis) and isotype. Only sequences with% 10% mutation
frequencies are shown. See also Figure S4 and Table S1.
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Table 1. SHM in the Ab Repertoire as Determined by High-Throughput Sequencing
Sample Isotype
Mean Mutation
Count
Mean Mutation
Frequency
Sequences with >0
Mutations
Sequences with >1
Mutation
Sequences with Mutation
FrequencyR0.01
Untreated IgM 2.900 0.008 26.3% 15.7% 10.3%
CpG div IgM 3.250 0.009 29.4% 14.2% 9.0%
CpG non-div IgM 3.230 0.009 25.4% 13.1% 9.3%
FO1 IgM 0.831 0.002 18.0% 6.4% 2.8%
FO2 IgM 0.807 0.002 17.2% 6.0% 2.6%
MZ1 IgM 1.021 0.003 20.8% 8.1% 3.4%
MZ2 IgM 0.911 0.003 21.4% 8.4% 3.3%
D7PB IgM 3.088 0.009 66.5% 23.3% 6.0%
D7PB IgG 3.854 0.011 77.6% 39.6% 21.4%
D7PB IgA 8.859 0.025 93.8% 73.4% 71.9%
D21PB1 IgM 1.914 0.005 49.2% 14.4% 4.4%
D21PB1 IgG 2.683 0.007 75.7% 35.6% 12.0%
D21PB1 IgA 8.913 0.025 97.5% 90.7% 76.6%
D21PB2 IgM 3.700 0.010 67.0% 31.7% 18.5%
D21PB2 IgG 8.043 0.022 93.5% 67.3% 51.8%
D21PB2 IgA 7.575 0.021 98.2% 80.2% 71.3%
D21PB3 IgM 4.645 0.013 65.4% 26.6% 13.1%
D21PB3 IgG 4.538 0.013 87.2% 36.4% 17.8%
D21PB3 IgA 9.281 0.026 94.9% 78.1% 65.3%
For naı¨ve B cells, follicular and marginal zone B cells from two mice were analyzed separately. No significant differences were seen, and data are
pooled here.only found by overexposing PNA; they also expressed low, but
detectable, amounts of the GC marker Bcl6 (Figure S5). These
clusters, which we refer to as ‘‘GC-like,’’ were found at an atyp-
ical site—the interface between the B and T cell zones—and did
not appear to develop past this stage into proper GCs for the
duration of our studies, up to 6 weeks after infection. A similar
response was observed in BALB/c mice, with lack of proper
GCs and a remarkable EF plasmablast response (Figure 3;
data not shown). Together these data suggest that GCs could
potentially form at late time points, but do not mature. We
considered whether innate immune signals in this context could
in fact suppress GC formation. Indeed, when BALB/c mice
deficient for MyD88 were infected, fully developed GCs were
observed as early as 10 days after infection, accompanied
by EF plasmablasts, and were more numerous by day 15
(Figure S5). However, this was not observed in C57BL/6
MyD88-deficient animals, indicating that additional factors may
suppress GC formation in a strain-specific manner.
To address whether SHM takes place in ‘‘GC-like’’ structures
and/or at EF sites, we performed laser capture microdissection
(LCM) and V region sequencing of both structures (example, Fig-
ure 5A) at 3 weeks post-infection. Picks comprised 20 to 30 cells
and in the case of plasmablasts, whenever possible, the same
patches were taken from two or three consecutive slides. We
dissected both adjacent and distant patches (Table S2). 14 plas-
mablast picks yielded a PCR product that was then cloned,
followed by sequencing of V gene inserts in multiple colonies
derived from each product. 79% of the unique sequences ob-
tained showed some somatic mutations, averaging 3.2 muta-
tions per mutated sequence (Tables S3 and S4). When clonally126 Immunity 43, 120–131, July 21, 2015 ª2015 Elsevier Inc.related sequences (with the same VDJ rearrangement) were
found, then a lineage tree was built that describes the evolution
of the clone. 11 of 14 picks gave clones to generate lineage trees.
Such trees demonstrate that ongoing V region diversification
was taking place among the few cells captured in each such mi-
crodissected patch. Figure 5B–5D shows representative trees
(see also Figure S6); in some cases (Figures 5B and 5C) the trees
were fairly simple, with two or three clonally related sequences
that were exclusively derived from the same pick. In other cases,
there was higher complexity, with sequences from different,
though adjacent, picks (Figure 5D). The mutations observed in
the lineage trees were authentic and not a result of PCR error:
the rates are far higher than that expected from PCR error using
high-fidelity polymerases (William et al., 2002). Moreover, the
presence of shared mutations is not expected from PCR error,
but is expected from clonal expansion and selection of authentic
SHM. The isolation of the same mutation from different picks of
the same geographic patch (i.e., taken from different serial sec-
tions), and hence different PCR amplifications fully excludes
PCR error as the explanation. Rather, when one considers that
it takes only 4 divisions to create a cluster of 16 cells, and that
SHM in GCs introduces about 0.25 mutations/V region/division,
then the extent of mutation is consistent with this high rate, as
there should be roughly 1 difference between each sequence
(Kleinstein et al., 2003). In parallel, we dissected and sequenced
some of the GC-like structures. A similar degree of SHM was
observed in these structures, with 70% of the sequences being
mutated with an average of 2.3 mutations per mutated sequence
(Table S3). Overall, these data show that there is robust diversi-
fication through SHM, and as extensively shown and discussed
Figure 5. Ongoing SHM Takes Place in Plasmablast Patches
(A) Example of a plasmablast patch pick by laser capture and microdissection
(LCM); the same patch is shown before and after the pick. The black line in-
dicates the area of20 cells that was dissected. The plasmablast patches are
identified with anti-CD138 staining by immunohistochemistry.
(B–D) Examples of three clonal trees of different complexity derived from the
analysis of the Ab gene sequences obtained by LCM. The size of each node
indicates the number of identical sequences found. In (D), amore complex tree
is shown that was composed of sequences that derived from several nearby
picks; different colors of the nodes denote different, but adjacent, picks from
which the sequence was derived, while the numberwithin the node indicates in
how many serial slides (always from the same patch) the same sequence was
found. The gray circle indicates an inferred intermediate. The position of the
mutated nucleotides and aminoacids (in the case of replacement mutations)
are shown along the branches. See also Figure S6 and Tables S2–S4.below, that this is likely to occur locally and determine affinity
maturation.
SHM Results in Efficient Affinity Maturation
If SHM-driven affinity maturation promotes development of
apparent Ag-specificity, then Ag-specific hybridomas should
have more mutations and these mutations should directly pro-
mote Ag-binding. Indeed, hybridomas that were assigned to
STm specificity had on average more than three mutations/
sequence, more than those with unknown specificity (Figure 6A).
To address the function of these mutations, we selected fourhybridomas with known specificity and that carried several mu-
tations. We then cloned and expressed their V regions in recom-
binant form (Wardemann et al., 2003) and generated complete
germlinemutational revertants, aswell as some partially mutated
intermediates (Figure 6B). First, we investigated LPS-specific
mAbs; three different but clonally related hybridomas were iso-
lated that carried both shared and unique mutations. Affinity
decreased markedly as mutations were removed, both for the
heavy and the light chain (Figure 6C). In particular, a mutation
leading to lysine (K) in position 66, which was shared by all
isolated hybridomas and hence arose early in the lineage,
appeared to have a large effect, as an artificial intermediate
version without it (green line) showed a dramatic reduction in af-
finity. Importantly, when either the heavy or the light chains were
reverted to germline, these mAbs showed no detectable binding
to LPS. The remaining portion of the spleen that was not used to
generate these hybridomas was used for LCM experiments;
remarkably, this same LPS-specific clone was also identified in
one of the largest dissected patches (Table S3). Hence, in this
case we could link affinity maturation to the EF site. The correla-
tion between SHM and affinity was confirmed for another mAb,
specific for the STm lysate (Figure 6D), that showed stepwise
loss of affinity as mutations were reverted, with binding of the
germline revertant only slightly above background. This mAb
carried several mutations in the heavy chain only, but had a
germline light chain. Thus, we found that SHM via a series of
steps had increased the affinity for STm antigens from barely
or not detectable to a high degree of binding.
DISCUSSION
Given that STm was reported to induce only delayed GC re-
sponses, we sought to determine the nature of the alternative
B cell response and whether this could create affinity matured
Ab and memory. Our initial observation was that the massive
AFC response to STm appeared to be largely non-specific.
The lack of apparent specificity was determined by multiple
methods, perhaps most convincingly by screening large panels
of mAbs on a Salmonella Ag microarray, as well as against
STm lysate and intact bacteria. We sought possible explanations
for the broad B cell response seen in the STm infection model.
Despite having tested key elements of TLR, IL-1R, and inflam-
masome pathways, we have not yet uncovered a receptor that
could explain non-specific activation of B cells, though we
cannot exclude that one exists.
Rather, several lines of evidence suggested that the response
is in fact specific, but of very low affinity. A critical test of this idea
was the assessment of the response in a variety of different mice
with restricted BCR repertoires. Restriction of the BCR repertoire
greatly reduced the response, which diminished according to the
degree of repertoire restriction, and almost disappeared when
both VH and VL were limited. In contrast, a truly non-specific
response would have been unaffected by B cell repertoire re-
striction. We propose a model in which promiscuously selected,
yet specifically stimulated, B cells then undergo mutation and
selection at EF sites to eventually generate what appears to be
Ag-specific cells at late time points.
Consistent with the model Ag-specific cells indeed emerged
for the most part only late during the response. This would beImmunity 43, 120–131, July 21, 2015 ª2015 Elsevier Inc. 127
Figure 6. Effect of SHM on Affinity in
Cloned mAbs
(A) Number of mutations in Ab sequences from
hybridoma clones.
(B) Diagram indicating the relationships between
the mAbs we isolated and the mutants we made,
with respect to the heavy chain. The letters inside
the circles represent amino acid substitutions as
compared to the germline (GL, black circle on top).
Circles on a gray background represent Abs that
were found in the hybridoma screening; dotted
circles on white background represent artificial
intermediate versions.
(C and D) Binding curves of recombinant mAbs
expressed in their original or germline form, as well
as in artificially mutated intermediate versions. The
asterisks indicate the original sequences isolated
from the hybridoma clones. An IgG sandwich
ELISA was performed in parallel to confirm that all
Abs were used in equal amounts in the assay (data
not shown).expected if the response were of such low affinity that standard
immunoassays could not usually detect the specificity until and
unless somatic mutation and selection improved the affinities.
In line with this, most of the mAbs with demonstrable STm
specificity were encoded by mutated genes, while most ‘‘non-
specific’’ mAbs were unmutated. This supports either of two
scenarios: that most Abs are in fact specific for STm, but it is
necessary that they mutate and mature in order to gain sufficient
affinity to be detected; or alternatively, that most Abs are not
specific and that only those few with some low degree of affinity
in their germline configuration can enter a pathway that allow
them tomature. To help distinguish these scenarios, we reverted
mutations observed in specific Abs. In the two cases tested,
the binding of Abs to their target was strongly dependent on
affinity gains determined by mutated amino acids, as shown by
the stepwise loss of reactivity as such mutated genes were pro-
gressively reverted to their germline. This result strongly argues
that a broad repertoire of B cells that have a very low initial affinity
for the antigen get activated and only later in the response
become detectable as Ag-specific as a consequence of affinity
maturation.
A key finding of our work is that the process that generates
higher affinity Abs from these low-affinity precursors does not
appear to depend on GCs, which have been canonically thought
to be the exclusive site for SHM. Two pathways might contribute
to this. The first involves small ‘‘GC-like’’ structures that occa-
sionally appeared about 3 weeks after infection; these consisted
of a small number of weakly PNA+ and Bcl6+ cells at the B-T cell
border rather than the follicular center site of classical GCs.
These cells might represent partially differentiated or immature
GC B cells. These structures remained at a primitive stage
without fully developing to GCs, even at later time points. The
second pathway involves the EF site, where indeed V region128 Immunity 43, 120–131, July 21, 2015 ª2015 Elsevier Inc.mutations do occur during the expansion
of the response. Notably, a similar phe-
nomenon was described before in auto-
immune lupus-prone mice (William et al.,
2002) and to some extent in humans innon-lymphoid sites such as synovia or rheumatoid arthritis
patients (Kim et al., 1999; Scheel et al., 2011; Schro¨der et al.,
1996; Stott et al., 1998).
In fact, SHM took place vigorously within both pathways,
and especially at EF sites. The mutational process itself could
occur in plasmablasts, as well as in B blasts, both of which
were shown in other contexts to express AID (Marshall et al.,
2011; Odegard et al., 2008; Toellner et al., 1996). Clearly,
isotype switching, mainly to IgG2c, another AID-dependent
process, was also occurring at these sites. The extent of
SHM in GC-like areas was not higher than in EF patches,
and 25% to 40% of sequences within the GC-like structures
(but not in EF patches) harbored stop codons in the comple-
mentarity determining region-3 (CDR3) region. Importantly,
GC-like structures and adjacent EF locations did not share
B cell clones, thus further pointing to a different origin of these
two structures. As was shown originally in classic work
proving that GCs were sites of SHM (Jacob et al., 1991), iden-
tical or clonal sequences sharing common mutations and VDJ
junctions were found within small clusters of 10–20 cells. This
could only arise if mutations were actively being incorporated
into V regions of dividing cells at that site. In our dataset,
clonally related sequences were found in the same patch
dissected from consecutive serial sections or, in some cases,
from adjacent patches, but never among sequences derived
from more distant sites. This further indicates that a substan-
tial proportion of the mutations we observed occurred locally,
because clonal sequences would not be confined to local
picks had mutations happened elsewhere. Though SHM
actively takes place at both locations, based on the earlier
appearance and much greater overall size of the EF patches,
we suggest that these are likely the source of the majority of
the affinity-matured ‘‘specific’’ AFCs.
This conclusion is directly supported by one case in
point, in which the spleen from an infected mouse was
used to perform both LCM and hybridoma production. Se-
quences were found among the plasmablast LCM picks that
were clonally related to LPS-specific mAbs identified in the
hybridoma screening. Importantly, this clone was shown in
our mAb revertant experiments to have strong binding to
LPS that was very much dependent on somatic mutations.
Hence, this allowed us to directly show affinity maturation
within an EF plasmablast-derived clone that was actively
undergoing SHM.
At the broadest level, our results suggest a revised view of how
clonal selection and affinity maturation operate in the response
to a pathogen. The response is dominated by plasmablast for-
mation at EF sites for at least several weeks. Plasmablasts
uniquely can both expand and generate effector function,
secreting Ig.We propose that such a response evolved to ensure
protective function to rapidly replicating pathogens and needs to
be generated as quickly as possible; failure to do so might result
in death.
A major insight from this report is that these responses
achieve great magnitude by engaging extremely low affinity
B cells; yet the response is far from ‘‘non-specific.’’ Moreover,
to a substantial degree this early response is independent of
T cells and hence needn’t wait for effective T cell priming.
This strategy would not only provide a measure of immediately
effective pathogen protection, it also would generate a large
number of clones that can subsequently be optimized. As we
and others (Marshall et al., 2011; Toellner et al., 1996) show,
plasmablasts and B blasts can quickly undergo isotype switch,
a process independent of GCs and even to some degree of
T cells; thus, a variety of effector functions aside from IgM
are rapidly engaged. Isotype switching is a process that re-
quires AID activity, which is also necessary and sufficient for
SHM (Muramatsu et al., 2000). The fact that extensive isotype
switching takes place in the EF response thus unequivocally
indicates that functional AID is being expressed. It has further
been established that AID is expressed in EF responses, at
least in some models (Marshall et al., 2011; Odegard et al.,
2008). Indeed, a second important finding is the unexpected
discovery that the EF plasmablast response is permissive for
SHM and in fact affinity-based selection. The evidence from
the microdissection data, the high-throughput sequencing
data, and the hybridoma sequencing data, together demon-
strate that at least some and probably most of the mutations
do occur at EF sites. In conclusion, SHM and affinity selection
serve to improve the initial, GC-independent, low affinity
response in a progressive way, as our mAb mutation and re-
expression analysis demonstrated.
While at present this pathway has been demonstrated for
Salmonella, as we have noted, a large, potentially ‘‘non-specific’’
early plasmablast response is a feature of immune responses to
many pathogens; hence, it is likely that other aspects such as low
starting affinity, early expression of AID, and GC-independent
onset of SHM and affinity maturation, will be featured in re-
sponses to other pathogens. If so, then the textbook depiction
of the humoral immune response might need to be modified
to include this physiologically important alternative to the GC-
dependent affinity maturation pathway.EXPERIMENTAL PROCEDURES
Mice, Bacteria, and Infection Procedures
The mice strains used in this study were obtained as described in the Supple-
mental Information and bred under specific pathogen free conditions in
the animal facility at Yale University. The aroA attenuated Salmonella Typhimu-
rium strain SL3261 (Hoiseth and Stocker, 1981) was kindly provided by Roy
Curtiss III, Arizona State University. For infection, 105 bacteria (unless other-
wise specified) in PBS were injected i.p. The bacterial burden was assessed
by plating serial dilutions of tissue homogenates, prepared by 1 mm-beads
disruption in a FastPrep-24 instrument (MP Biomedicals). All mouse work
was according to protocols approved by the Yale Institutional Animal Care
and Use Committee.
Immunofluorescence Assays
7 mmspleen sections were prepared fromOCT-frozen tissues, fixed in acetone
for 10 min, and stored at 80C. Antibodies and procedures used are
described in Supplemental Information.
Antigens
Salmonella Typhimurium LPS was purchased from Sigma. A STm lysate was
obtained by cell disruption using 0.1 mm beads in a FastPrep-24 instrument
(MP Biomedicals). Recombinant antigens were generated by cloning STm
genes in the pGEX-6P-1 vector (GE Life Sciences) vector. The following genes
of interest were amplified directly from the same SL3261 STm strain used for
the following infections: ompA, ompD, ybhC, FliC, and FljB. The recombinant
plasmids were transformed in E. coli and GST-tagged recombinant proteins
were produced and purified with Glutathione Sepharose 4B (GE Life Sciences)
according to standard protocols.
ELISpot and Flow Cytometry Analysis of Splenocytes
Single cell suspensions from spleen were obtained by mechanical disruption
of the tissue, followed by treatment with ACK buffer for lysis of red blood
cells. For ELISpot assay, Immulon 4-HBX plates were coated with the
following antigens: anti-kappa at 5 mg/ml, LPS at 5 mg/ml, STm lysate at
50 mg/ml, recombinant antigens at 10 mg/ml. Non-specific binding was
blocked with 1% bovine serum albumin in PBS. Splenocytes were incubated
for 6 hr at 37C. AFCs were detected by using alkaline phosphatase-conju-
gated secondary antibodies (to IgG or IgM, Southern Biotech) and 5-bromo-
4-chloro-3-indolyl-phosphate in agarose. For flow cytometry experiments,
antibodies were purified in the laboratory or purchased as indicated in the
Supplemental Information. Nonspecific binding to Fcg receptors was
blocked with the anti-FcR clone 2.4G2; dead cells were excluded by
ethidium monoazide staining, and doublets by scatter analysis. Cells were
analyzed on a LSRII instrument (BD) and data analyzed by FlowJo software
(TreeStar).
mAb Production and Screening
Hybridoma lines and clones were generated as reported in Supplemental In-
formation. The original Ab genes were amplified (Tiller et al., 2009) from
cDNA generated from hybridoma clones. Briefly, RNA was isolated using
the RNeasy Mini kit (QIAGEN) per the manufacturer protocol, and cDNA pre-
pared with the iScript cDNA synthesis kit (Bio-Rad) using random hexamers.
Germline revertants or intermediate versions were generated by oligonucle-
otide-directed mutagenesis and then assembled by PCR. Recombinant
mAbs were produced as described elsewhere (Wardemann et al., 2003).
The amount of each recombinant mAb was estimated by an IgG sandwich
ELISA and compared to a standard. For ELISA, antigens were coated O/N
on Immulon 2-HBX plates at the same concentrations reported above and
as described in Supplemental Information. Live bacterial flow cytometry
was performed as follows: STm was grown O/N in LB media, aliquoted in
a 96-well plate at approximately 106 bacteria per well and spun down. Bac-
teria were resuspended in undiluted hybridoma supernatant and incubated
for 1 hr. After washing with PBS, an Alexa-488-labeled anti-kappa secondary
Ab was added. After 30 min, bacteria were washed, fixed in 1.5% PFA, and
analyzed on a FACSCalibur (BD). Microarrays were fabricated and probed
with undiluted hybridoma supernatants as described previously (Lee et al.,
2012).Immunity 43, 120–131, July 21, 2015 ª2015 Elsevier Inc. 129
Cell Sorting and High-Throughput Repertoire Sequence Analysis
Plasmablasts, naive follicular B cells, marginal zone B cells, and the cells
for CpG DNA stimulation were obtained and treated as described in detail in
Supplemental Information. For all cell types, after sorting cells were spun
down and RNA isolated as described above. 250 ng of RNA was reverse-
transcribed into cDNA using a biotinylated oligo dT primer. Libraries were
created and sequenced as described in detail in the Supplemental Informa-
tion. Raw high-throughput sequencing reads were quality controlled, assem-
bled and filtered using pRESTO (Vander Heiden et al., 2014). V(D)J germline
segments were determined using IMGT/HighV-QUEST (Alamyar et al.,
2012). Clonal clustering was carried out and lineage inference was performed
on each cluster using the software package PHYLIP 3.6 (N.T.G., unpublished
data).
Laser Capture Microdissection
7 mm spleen sections were prepared from OCT-frozen tissues on the mem-
brane-coated PEN slides (Leica). Plasmablast patches were detected using
anti-CD138 and GC-like structures using PNA and anti-IgD in immunohisto-
chemistry as reported in Supplemental Information. Microdissections were
performed using a Leica LMD6500 instrument equipped with an optical micro-
scope. Dissected patches were collected in the cap of PCRmicrotubes in 10 ml
of digestion buffer (50 mM Tris-HCl, 50mMKCl, 0.63 mMEDTA, 0.22% Igepal,
0.22% Tween20, 0.8 mg/ml proteinase K). Patches were digested at 55C for
2 hr, then at 90C for 5 min, and used for PCR amplification of Ab genes.
Primers, PCR procedures, and data analysis are described in Supplemental
Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, four tables, and Supplemental
Experimental Procedures and can be found with this article online at http://dx.
doi.org/10.1016/j.immuni.2015.06.013.
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